- Upcoming events
- About TMA
- Mission Areas
- Case Stories
MD, Western University – London ON Canada
Rob Hegele is a Distinguished University Professor and an endocrinologist with an interest in lipidology and diabetes, who cares for >1800 patients. He is the Director of the Blackburn Cardiovascular Genetics Lab and London Regional Genomics Centre. He has trained many physicians in lipidology and several graduate students in human genetics. His laboratory has studied the genetic basis of diabetes and atherosclerosis in Canadian sub-populations and aboriginal communities. His lab discovered the molecular genetic basis of 20 human diseases, including hepatic lipase deficiency, Oji-Cree type 2 diabetes, familial partial lipodystrophy and endocrine-cerebro-ostedysplasia and has described >100 human mutations causing dyslipidemia, diabetes and atherosclerosis. He has published >600 peer-reviewed articles and serves on numerous journal editorial boards, including Lancet Diabetes and Endocrinology, Circulation, Stroke, ATVB and Journal of Lipid Research. He has received numerous international awards recognizing his research and his work has been cited >18,000 times in the biomedical literature. He was first in North America to use several new lipid lowering therapies. He is listed in the ISI Web of Knowledge database as being in the top 1% of highly cited scientists in the world.